Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04198766
Brief Title: Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

First Submitted : December 11, 2019
First Submitted that Met QC Criteria : December 11, 2019
First Posted : December 13, 2019

Last Update Submitted that Met QC Criteria : July 16, 2021
Last Update Posted : July 20, 2021